Petmed Express Inc (NASDAQ:PETS) Director Ronald J. Korn sold 5,000 shares of the firm’s stock in a transaction that occurred on Monday, January 29th. The stock was sold at an average price of $48.38, for a total transaction of $241,900.00. Following the transaction, the director now owns 68,833 shares in the company, valued at $3,330,140.54. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.

Petmed Express Inc (PETS) opened at $44.37 on Friday. The stock has a market cap of $914.21, a P/E ratio of 26.25, a PEG ratio of 2.75 and a beta of 1.12. Petmed Express Inc has a 1 year low of $19.21 and a 1 year high of $57.80.

Petmed Express (NASDAQ:PETS) last announced its earnings results on Monday, January 22nd. The company reported $0.44 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.33 by $0.11. The business had revenue of $60.10 million for the quarter, compared to analyst estimates of $56.76 million. Petmed Express had a net margin of 12.84% and a return on equity of 34.04%. The company’s revenue for the quarter was up 13.6% compared to the same quarter last year. During the same period last year, the firm posted $0.24 earnings per share. analysts forecast that Petmed Express Inc will post 1.7 EPS for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, February 16th. Investors of record on Monday, February 5th will be given a $0.25 dividend. This represents a $1.00 dividend on an annualized basis and a yield of 2.25%. This is a positive change from Petmed Express’s previous quarterly dividend of $0.20. The ex-dividend date is Friday, February 2nd. Petmed Express’s dividend payout ratio (DPR) is 47.34%.

A number of large investors have recently bought and sold shares of the stock. Chicago Equity Partners LLC grew its position in Petmed Express by 139.5% in the 4th quarter. Chicago Equity Partners LLC now owns 19,590 shares of the company’s stock valued at $891,000 after buying an additional 11,410 shares during the last quarter. Weatherly Asset Management L. P. purchased a new position in Petmed Express in the 4th quarter valued at $212,000. Sterling Investment Advisors Ltd. grew its position in Petmed Express by 118.5% in the 4th quarter. Sterling Investment Advisors Ltd. now owns 2,950 shares of the company’s stock valued at $134,000 after buying an additional 1,600 shares during the last quarter. Fisher Asset Management LLC grew its position in Petmed Express by 13.2% in the 4th quarter. Fisher Asset Management LLC now owns 143,513 shares of the company’s stock valued at $6,530,000 after buying an additional 16,716 shares during the last quarter. Finally, Personal Capital Advisors Corp grew its position in Petmed Express by 11.0% in the 4th quarter. Personal Capital Advisors Corp now owns 71,417 shares of the company’s stock valued at $3,249,000 after buying an additional 7,059 shares during the last quarter. Hedge funds and other institutional investors own 97.81% of the company’s stock.

A number of equities analysts have recently issued reports on PETS shares. Zacks Investment Research upgraded shares of Petmed Express from a “sell” rating to a “hold” rating and set a $50.00 target price on the stock in a research report on Friday, October 20th. Noble Financial restated a “hold” rating on shares of Petmed Express in a research report on Friday, October 27th. BidaskClub upgraded shares of Petmed Express from a “buy” rating to a “strong-buy” rating in a research report on Saturday, December 9th. Finally, Northcoast Research set a $58.00 target price on shares of Petmed Express and gave the stock a “buy” rating in a research report on Wednesday, January 3rd. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and three have issued a buy rating to the company. Petmed Express presently has a consensus rating of “Hold” and a consensus target price of $42.80.

TRADEMARK VIOLATION NOTICE: “Insider Selling: Petmed Express Inc (PETS) Director Sells 5,000 Shares of Stock” was first posted by Daily Political and is the property of of Daily Political. If you are viewing this piece on another website, it was illegally stolen and reposted in violation of U.S. & international copyright legislation. The original version of this piece can be viewed at https://www.dailypolitical.com/2018/02/02/insider-selling-petmed-express-inc-pets-director-sells-5000-shares-of-stock.html.

About Petmed Express

PetMed Express, Inc (PetMed Express), doing business as 1800PetMeds, is a pet pharmacy. The Company markets prescription and non-prescription pet medications, and other health products for dogs and cats, direct to the consumer. It offers a selection of products for dogs and cats. Its product line contains approximately 3,000 stock keeping units (SKUS) of pet medications, health products and supplies.

Insider Buying and Selling by Quarter for Petmed Express (NASDAQ:PETS)

Receive News & Ratings for Petmed Express Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Petmed Express and related companies with MarketBeat.com's FREE daily email newsletter.